恶性疟原虫富含谷氨酸蛋白非依赖性多克隆抗体抑制人红细胞内疟原虫生长
该研究使用抗PfGARP多克隆抗体和单克隆抗体mAb7899,发现抗PfGARP多克隆抗体(而非mAb7899)在感染红细胞中发挥强效的疟原虫生长抑制作用,且该抑制不依赖于PfGARP。结果提示,针对PfGARP产生的多克隆抗体可能通过未知疟疾蛋白靶点导致生长停滞。
要点
- 抗PfGARP多克隆抗体强效抑制感染红细胞内疟原虫生长。
- 单克隆抗体mAb7899对疟原虫生长无抑制作用。
- 多克隆抗体的生长抑制不依赖于PfGARP蛋白。
核心结论
- 抗PfGARP多克隆抗体而非mAb7899在感染红细胞中独立于PfGARP发挥强效的疟原虫生长抑制作用。
- 提示针对PfGARP产生的多克隆抗体可能靶向未知疟疾蛋白导致生长停滞。
研究设计与样本
- 使用抗PfGARP多克隆抗体和单克隆抗体mAb7899进行实验。
主要发现
- 抗PfGARP多克隆抗体对感染红细胞内疟原虫生长发挥强效抑制。
- 单克隆抗体mAb7899未表现出对疟原虫生长的抑制。
- 多克隆抗体的生长抑制不依赖于PfGARP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Plasmodium falciparum glutamic acid-rich protein (PfGARP) is a recently characterized cell surface antigen encoded by Plasmodium falciparum, the causative agent of severe human malaria pathophysiology. Previously, we reported that the human erythrocyte band 3 (SLC4A1) serves as a host receptor for PfGARP. Antibodies against PfGARP did not affect parasite invasion and growth. We surmised that PfGARP may play a role in the rosetting and adhesion of malaria. Another study reported that antibodies targeting PfGARP exhibit potent inhibition of parasite growth. This inhibition occurred without the presence of any immune or complement components, suggesting the activation of an inherent density-dependent regulatory system. Here, we used polyclonal antibodies against PfGARP and a monoclonal antibody mAb7899 to demonstrate that anti-PfGARP polyclonal antibodies, but not mAb7899, exerted potent inhibition of parasite growth in infected erythrocytes independent of PfGARP. These findings suggest that an unknown malaria protein(s) is the target of growth arrest by polyclonal antibodies raised against PfGARP.
引用
- Schwake CJ, Krueger RM, Hanada T, et al. Plasmodium falciparum Glutamic Acid-Rich Protein-Independent Polyclonal Antibodies Inhibit Malaria Parasite Growth in Human Erythrocytes. J Infect Dis. 2024. PMID: 38298126. doi:10.1093/infdis/jiae050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。